SEC Form 4 · accession 0001140361-15-040838
Genpact LTD · G
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert G Scott
Director
Period of report
Nov 9, 2015
Accepted (ET)
Nov 12, 2015 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001398659
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Nov 9, 2015 | M | 10,000 | $5.7351 | A | 92,979 | D | |
| Common SharesF2 | Nov 9, 2015 | S | 10,000 | $24.8528 | D | 82,979 | D | |
| Common SharesF1 | Nov 10, 2015 | M | 25,000 | $5.7351 | A | 107,979 | D | |
| Common SharesF3 | Nov 10, 2015 | S | 25,000 | $25.07 | D | 82,979 | D | |
| Common SharesF1 | Nov 11, 2015 | M | 35,000 | $5.7351 | A | 117,979 | D | |
| Common SharesF4 | Nov 11, 2015 | S | 35,000 | $25.62 | D | 82,979 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F6,F1,F5 | $5.7351 | Nov 9, 2015 | M | 10,000 | D | — | Feb 27, 2016 | Common Shares | 10,000 | 82,353 | D |
| Employee Stock Option (Right to Buy)F6,F1,F5 | $5.7351 | Nov 10, 2015 | M | 25,000 | D | — | Feb 27, 2016 | Common Shares | 25,000 | 57,353 | D |
| Employee Stock Option (Right to Buy)F6,F1,F5 | $5.7351 | Nov 11, 2015 | M | 35,000 | D | — | Feb 27, 2016 | Common Shares | 35,000 | 22,353 | D |
Explanation of responses
- F1The exercise price reflects an adjustment that was made to preserve the value of the Reporting Person's outstanding stock options following the special cash dividend paid by Genpact Limited on September 24, 2012 to holders of record as of September 10, 2012.
- F2The price in column 4 is a weighted average price. The actual sale prices for these transactions ranged from $24.850 to $24.865. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F3The price in column 4 is a weighted average price $25.07. The actual sale prices for these transactions ranged from $25.00 to $25.14. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F4The price in column 4 is a weighted average price $25.62. The actual sale prices for these transactions ranged from $25.27 to $25.93. The Reporting Person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F5The options vested 20% on April 20, 2007; and 5% vests on each subsequent quarter thereafter.
- F6The number of derivative securities beneficially owned reflects an adjustment that was made to preserve the value of the Reporting Person's outstanding stock options following the special cash dividend paid by Genpact Limited on September 24, 2012 to holders of record as of September 10, 2012.